Baroda BNP Paribas Innovation Fund Regular plan - Growth Option

Baroda BNP Paribas Innovation Fund Regular plan - Growth Option sits in the middle of the pack for Thematic funds, backed by a 4-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 64/100.

Cost: At 1.43%, the expense ratio runs 29% above the Thematic category average of 1.11%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a modest Sharpe ratio of 0.3 — returns have only marginally compensated for the risk taken. Separately, annualised volatility of 15.23% is fairly typical for actively managed equity funds.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.